Get our Free Patent Expiration Newsletter

Serving leading biopharmaceutical companies globally:

McKesson
Dow
Colorcon
Baxter
McKinsey
Merck

Last Updated: October 16, 2019

DrugPatentWatch Database Preview

FLAVORED COLESTID Drug Profile

See Plans and Pricing

« Back to Dashboard

Which patents cover Flavored Colestid, and when can generic versions of Flavored Colestid launch?

Flavored Colestid is a drug marketed by Pharmacia Upjohn and is included in one NDA.

The generic ingredient in FLAVORED COLESTID is colestipol hydrochloride. There are two drug master file entries for this compound. Three suppliers are listed for this compound. Additional details are available on the colestipol hydrochloride profile page.

Drug patent expirations by year for FLAVORED COLESTID
Drug Prices for FLAVORED COLESTID

See drug prices for FLAVORED COLESTID

Recent Clinical Trials for FLAVORED COLESTID

Identify potential brand extensions & 505(b)(2) entrants

SponsorPhase
National Heart, Lung, and Blood Institute (NHLBI)Phase 3
University of WashingtonPhase 3

See all FLAVORED COLESTID clinical trials

Pharmacology for FLAVORED COLESTID
Synonyms for FLAVORED COLESTID
37296-80-3
AC1MJ2ZS
C11H28ClN5O.HCl
C60H114O8.HCl
Colestid
Colestipol HCl
Colestipol hydrochloride
Colestipol hydrochloride [USAN:USP]
Colestipol hydrochloride [USAN]
Copolymer of diethylenetriamine and 1-chloro-2,3-epoxypropane, hydrochloride (with approximately 1 out of 5 amine nitrogens protonated)
DTXSID40190737
FT-0749664
GACQNVJDWUAPFY-UHFFFAOYSA-N
Lestid
LS-54700
N'-[2-[2-(2-aminoethylamino)ethylamino]ethyl]ethane-1,2-diamine hydrochloride
SCHEMBL284758
tetraethylenepentamine HCl
U-26597A
UNII-X7D10K905G
X7D10K905G

US Patents and Regulatory Information for FLAVORED COLESTID

Applicant Tradename Generic Name Dosage NDA Approval Date TE Type RLD RS Patent No. Patent Expiration Product Substance Delist Req. Exclusivity Expiration
Pharmacia Upjohn FLAVORED COLESTID colestipol hydrochloride GRANULE;ORAL 017563-001 Approved Prior to Jan 1, 1982 RX Yes No   Request a Trial   Request a Trial   Request a Trial
Pharmacia Upjohn FLAVORED COLESTID colestipol hydrochloride GRANULE;ORAL 017563-002 Approved Prior to Jan 1, 1982 RX Yes No   Request a Trial   Request a Trial   Request a Trial
>Applicant >Tradename >Generic Name >Dosage >NDA >Approval Date >TE >Type >RLD >RS >Patent No. >Patent Expiration >Product >Substance >Delist Req. >Exclusivity Expiration

Expired US Patents for FLAVORED COLESTID

Applicant Tradename Generic Name Dosage NDA Approval Date Patent No. Patent Expiration
Pharmacia Upjohn FLAVORED COLESTID colestipol hydrochloride GRANULE;ORAL 017563-001 Approved Prior to Jan 1, 1982   Request a Trial   Request a Trial
Pharmacia Upjohn FLAVORED COLESTID colestipol hydrochloride GRANULE;ORAL 017563-002 Approved Prior to Jan 1, 1982   Request a Trial   Request a Trial
>Applicant >Tradename >Generic Name >Dosage >NDA >Approval Date >Patent No. >Patent Expiration

Make Better Decisions: Try a trial or see plans & pricing

Serving leading biopharmaceutical companies globally:

Moodys
Medtronic
Baxter
Mallinckrodt
Harvard Business School
Boehringer Ingelheim

Drugs may be covered by multiple patents or regulatory protections. All trademarks and applicant names are the property of their respective owners or licensors. Although great care is taken in the proper and correct provision of this service, thinkBiotech LLC does not accept any responsibility for possible consequences of errors or omissions in the provided data. The data presented herein is for information purposes only. There is no warranty that the data contained herein is error free. thinkBiotech performs no independent verifification of facts as provided by public sources nor are attempts made to provide legal or investing advice. Any reliance on data provided herein is done solely at the discretion of the user. Users of this service are advised to seek professional advice and independent confirmation before considering acting on any of the provided information. thinkBiotech LLC reserves the right to amend, extend or withdraw any part or all of the offered service without notice.